J Med Microbiol NEW Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online ahead of print on 15 June 2009 as doi:10.1099/jmm.0.008615-0
Journal of Medical Microbiology 2009;58:1030.

J Med Microbiol (2009), DOI: 10.1099/jmm.0.008615-0
© 2009 Society for General Microbiology
This Article
Right arrow Full Text (Papers in Press[PDF])
Right arrow Supplementary data
Right arrow All Versions of this Article:
jmm.0.008615-0v1
58/8/1030    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Woo, P. C.
Right arrow Articles by Yuen, K.-y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woo, P. C.
Right arrow Articles by Yuen, K.-y.
Agricola
Right arrow Articles by Woo, P. C.
Right arrow Articles by Yuen, K.-y.

Guidelines for interpretation of 16S rDNA sequence based results for identification of medically important aerobic Gram-positive bacteria

Patrick CY Woo, Jade LL Teng, Jeff KL Wu, Fion PS Leung, Herman Tse, Ami MY Fung, Susanna KP Lau and Kwok-yung Yuen1

The University of Hong Kong

1 E-mail: hkumicro{at}hkucc.hku.hk

Received December 10, 2008
Accepted May 3, 2009

The study is the first that provides guidelines for facilitating interpretation of results based on full and 527-bp 16S rDNA sequencing and Microseq databases used for identifying medically important aerobic Gram-positive bacteria. Overall, full and 527-bp 16S rDNA sequencing can identify 24% and 40% of medically important Gram-positive cocci and 21% and 34% of medically important Gram-positive rods confidently to the species level, whereas the full-MicroSeq and 500-MicroSeq databases can identify 15% and 34% of medically important Gram-positive cocci and 14% and 25% of medically important Gram-positive rods confidently to the species level. Among staphylococci, streptococci, enterococci, mycobacteria, corynebacteria, nocardia and members of Bacillus and related taxa (Paenibacillus, Brevibacillus, Geobacillus and Virgibacillus), the methods and databases are least useful for identification of staphylococci and nocardia. Only 0-2% and 2-13% of staphylococci and 0% and 0-10% of nocardia can be confidently and doubtfully identified respectively. On the other hand, these methods and databases are most useful for identification of Bacillus and related taxa, with 36-56% and 11-14% of Bacillus and related taxa confidently and doubtfully identified respectively. Fifteen medically important Gram-positive cocci and 18 medically important Gram-positive rods that should be confidently identified by full 16S rDNA sequencing are not included in the full-MicroSeq database. Nine medically important Gram-positive cocci and 21 medically important Gram-positive rods that should be confidently identified by 527-bp 16S rDNA sequencing are not included in the 500-MicroSeq database. 16S rDNA sequence results of Gram-positive bacteria should be interpreted with basic phenotypic tests results. Additional biochemical tests or sequencing of additional gene loci are often required for definitive identification. To improve the usefulness of the Microseq databases, bacterial species that can be confidently identified by 16S rDNA sequencing but not included in the MicroSeq databases should be included.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2009 Society for General Microbiology.